Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-first-quarter-2024-financial-results-and-business-update-302130846.html
https://www.prnewswire.com/news-releases/rigel-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302113555.html
https://www.prnewswire.com/news-releases/rigel-announces-publication-of-data-on-rezlidhia-olutasidenib-in-post-venetoclax-patients-with-mutant-idh1-aml-in-leukemia--lymphoma-302107833.html
https://www.prnewswire.com/news-releases/rigel-pharmaceuticals-announces-appointment-of-lisa-rojkjaer-md-as-chief-medical-officer-302086086.html
https://www.prnewswire.com/news-releases/rigel-reports-fourth-quarter-and-full-year-2023-financial-results-and-provides-business-update-302080342.html
https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-fourth-quarter-and-full-year-2023-financial-results-and-business-update-302071925.html
https://www.prnewswire.com/news-releases/rigel-pharmaceuticals-provides-business-update-302027953.html
https://www.prnewswire.com/news-releases/rigel-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302027467.html
https://www.prnewswire.com/news-releases/rigel-announces-collaboration-with-connect-to-conduct-a-phase-2-trial-of-olutasidenib-in-glioma-302026029.html
https://www.prnewswire.com/news-releases/rigel-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302025129.html